SEC FORM 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:		3235-0104
Expires:	December 31, 2014
Estimated average burden
hours per response:		0.5

1. Name and Address of Reporting Person ^*

Itescu Silviu

(Last)

(First)

(Middle)

LEVEL 38

55 COLLINS STREET

(Street)

MELBOURNE

3000

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
MESOBLAST LTD [ MESO ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
CEO and Managing Director

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	67,756,838	D
Ordinary Shares	8,821,137	I	Owned by Josaka Investments Pty Ltd, the trustee of Dr. Itescu's self-managed superannuation fund
Ordinary Shares	2,380,953	I	Owned by Tamit Nominees Pty Ltd, an Australian corporation owned by Dr. Itescu

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Option (right to buy)	07/19/2020	07/19/2026	Ordinary Shares	628,445	1.45	D
Option (right to buy)	07/19/2021	07/19/2026	Ordinary Shares	404,001	1.45	D
Option (right to buy)	07/19/2022	07/19/2026	Ordinary Shares	179,555	1.45	D
Option (right to buy)	08/24/2022	07/15/2027	Ordinary Shares	480,000	3.39	D
Option (right to buy)	07/16/2023	07/15/2027	Ordinary Shares	240,000	3.39	D
Option (right to buy)	07/21/2023	09/07/2028	Ordinary Shares	510,000	1.75	D
Option (right to buy)	04/12/2024	10/11/2030	Ordinary Shares	424,357	0.36	D
Option (right to buy)	05/15/2024	09/07/2028	Ordinary Shares	110,000	1.75	D
Option (right to buy)	07/12/2024	10/11/2030	Ordinary Shares	424,357	0.36	D
Option (right to buy)	10/12/2024	10/11/2030	Ordinary Shares	424,356	0.36	D
Option (right to buy)	10/15/2024	09/09/2031	Ordinary Shares	133,320	0.01	D
Option (right to buy)	10/16/2024	10/15/2030	Ordinary Shares	806,667	0.35	D
Option (right to buy)	10/30/2024	09/09/2031	Ordinary Shares	133,320	0.01	D
Option (right to buy)	11/15/2024	09/09/2031	Ordinary Shares	133,320	0.01	D
Option (right to buy)	11/29/2024	09/09/2031	Ordinary Shares	133,320	0.01	D
Option (right to buy)	12/16/2024	09/09/2031	Ordinary Shares	133,320	0.01	D
Option (right to buy)	01/08/2025	09/09/2031	Ordinary Shares	266,640	0.01	D
Option (right to buy)	01/20/2025	09/09/2031	Ordinary Shares	266,640	0.01	D
Option (right to buy)	02/27/2025	08/26/2031	Ordinary Shares	155,385	0.97	D
Option (right to buy)	02/28/2025	09/09/2031	Ordinary Shares	266,640	0.01	D
Option (right to buy)	03/17/2025	09/09/2031	Ordinary Shares	266,640	0.01	D
Option (right to buy)	03/31/2025	09/09/2031	Ordinary Shares	266,640	0.01	D
Option (right to buy)	04/15/2025	09/09/2031	Ordinary Shares	222,200	0.01	D
Option (right to buy)	05/10/2025	07/15/2027	Ordinary Shares	480,000	3.39	D
Option (right to buy)	05/27/2025	08/26/2031	Ordinary Shares	155,385	0.97	D
Option (right to buy)	08/27/2025	08/26/2031	Ordinary Shares	1,191,384	0.97	D
Option (right to buy)	10/16/2025	10/16/2029	Ordinary Shares	930,000	1.01	D
Option (right to buy)	10/16/2025	10/15/2030	Ordinary Shares	806,667	0.35	D

Explanation of Responses:

Remarks:

1. All exercise prices are in Australian dollars.

	/s/ Silviu Itescu	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.